Acetaminophen use in pregnancy: Examining prevalence, timing, and indication of use in a prospective birth cohort

被引:35
作者
Bandoli, Gretchen [1 ,2 ]
Palmsten, Kristin [3 ]
Chambers, Christina [1 ,2 ]
机构
[1] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA
[3] HealthPartners Inst, Minneapolis, MN USA
基金
英国医学研究理事会; 英国惠康基金;
关键词
acetaminophen; indications for use; pregnancy; prevalence; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; THE-COUNTER MEDICATIONS; PARACETAMOL EXPOSURE; RISK; DEPRESSION; WOMEN;
D O I
10.1111/ppe.12595
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Previous studies of prenatal acetaminophen use have not addressed what indications and maternal co-factors describe acetaminophen use. Objective The objective of this study was to describe these parameters in a well-characterised, prospective birth cohort. Methods Data were drawn from the MotherToBaby study of pregnant women enrolled from 2004 to 2018. Daily acetaminophen diaries were calculated for all exposed women with complete dose and duration information. Descriptive statistics were used to assess maternal characteristics associated with acetaminophen use. Prevalence by 2-year interval was described, and linear regression was used to test for trend. Indication of use and dose per indication were summarised. Results Of 2441 subjects, 1515 (62%) reported use of acetaminophen. Over the 15-year period, there was a decline in use of 2.5% for each 2-year period (test for trend = 0.001) with 58% reporting acetaminophen use in 2017-2018. Among women with acetaminophen use in pregnancy (n = 1515), 58% reported <10 days of use, 13% reported 10-19 days of use, 9% reported 20-44 days of use, and 9% reported 45 or more days of use. Twelve per cent had undefined duration of use. Increasing duration of exposure was associated with tobacco use, obesity, self-reported depression or anxiety, and antidepressant use. The most frequently reported indication was headache, however, indication varied by duration of use, with more women reporting use for sleep or pain/injury in the categories with the longest duration of use. Median dose per exposed day was highest among those reporting use for sleep, and higher doses were more frequently reported for arthritis, injury, and pain. Conclusion Acetaminophen is used by the majority of pregnant women, and some continue to use for many weeks in pregnancy. Given the heterogeneity in duration of use, indication, and dose, studies that estimate the risk of adverse outcomes associated with acetaminophen must carefully consider these factors.
引用
收藏
页码:237 / 246
页数:10
相关论文
共 32 条
[1]   Use of Acetaminophen (Paracetamol) During Pregnancy and the Risk of Attention-Deficit/Hyperactivity Disorder in the Offspring [J].
Andrade, Chittaranjan .
JOURNAL OF CLINICAL PSYCHIATRY, 2016, 77 (03) :E312-E314
[2]  
[Anonymous], 2015, FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood
[3]  
[Anonymous], 2017, AM J OBSTET GYNECOL
[4]  
[Anonymous], PHARMACOEPIDEMIOL DR
[5]  
[Anonymous], 1983, MANUAL STATE TRAIT A
[6]   Acetaminophen use in pregnancy and neurodevelopment: attention function and autism spectrum symptoms [J].
Avella-Garcia, Claudia B. ;
Julvez, Jordi ;
Fortuny, Joan ;
Rebordosa, Cristina ;
Garcia-Esteban, Raquel ;
Riano Galan, Isolina ;
Tardon, Adonina ;
Rodriguez-Bernal, Clara L. ;
Iniguez, Carmen ;
Andiarena, Ainara ;
Santa-Marina, Loreto ;
Sunyer, Jordi .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2016, 45 (06) :1987-1996
[7]   EFFECT OF NONDIFFERENTIAL MISCLASSIFICATION ON ESTIMATES OF ODDS RATIOS WITH MULTIPLE LEVELS OF EXPOSURE [J].
BIRKETT, NJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 136 (03) :356-362
[8]   Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study [J].
Brandlistuen, Ragnhild Eek ;
Ystrom, Eivind ;
Nulman, Irena ;
Koren, Gideon ;
Nordeng, Hedvig .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2013, 42 (06) :1702-1713
[9]   Pregnancy outcome in women exposed to leflunomide before or during pregnancy [J].
Cassina, M. ;
Johnson, D. L. ;
Robinson, L. K. ;
Braddock, S. R. ;
Xu, R. ;
Jimenez, J. L. ;
Mirrasoul, N. ;
Salas, E. ;
Luo, Y. J. ;
Jones, K. L. ;
Chambers, C. D. .
ARTHRITIS AND RHEUMATISM, 2012, 64 (07) :2085-2094
[10]   Birth outcomes in pregnant women taking fluoxetine [J].
Chambers, CD ;
Johnson, KA ;
Dick, LM ;
Felix, RJ ;
Jones, KL .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1010-1015